|CRM, RCL, NKTR, VICL, TTMI, AMSWA, Expected to Trade Lower After Bearish Insider Trading|
|[ Release Date: 03/20/2017 04:45 PDT ]
March 20, 2017 / M2 PRESSWIRE / BUYINS.NET / http://www.squeezetrigger.com is monitoring top insider trading patterns and these stocks are the most likely to trade Lower in the next 6 months. salesforce.com inc. (NYSE:CRM), Royal Caribbean Cruises Ltd. (NYSE:RCL), Nektar Therapeutics (NASDAQ:NKTR), Vical Incorporated (NASDAQ:VICL), TTM Technologies Inc. (NASDAQ:TTMI), American Software Inc. (NASDAQ:AMSWA) are all expected to go Lower as Sell signals have been generated by top insider trading patterns.
The most important data elements considered when performing insider analysis are:
Insiders Track Record - An insiders track record is best summarized by the Insider Score which ranges from 1 (least predictive) to 100 (most predictive) based on prior trading performance. In addition, the actual returns following the insiders prior trades are included to determine the potential magnitude of future returns.
Insiders Role - Trades by higher-level insiders are generally more predictive than trades by lower level insiders. Higher-level insiders to include Chairman (CB), Chief Executive Officer (CEO), President (P), Chief Financial Officer (CFO), and Vice Chairman (VC).
The chart below displays the stocks expected to go Lower along with the insider name, position, predictive insider score, 6 month expected return and number of trading decisions included in the score.
Symbol Company Name Insider Name Role Shares Insider Score Avg 6 Month Return # of Dec.
CRM salesforce.com inc. Block, Keith G P 10,000 98 -7.7% 9
RCL Royal Caribbean Cruises Ltd. Fain, Richard D CEO 20,000 87 -5.3% 13
NKTR Nektar Therapeutics Chess, Robert Bruce D 5,000 94 -10.0% 23
VICL Vical Incorporated Smith, Lawrence Russell O 875 99 -20.4% 11
TTMI TTM Technologies Inc. Alder, Kenton K D 3,000 95 -13.0% 53
AMSWA American Software Inc. Mcguone, James R O 4,023 93 -12.9% 13
The insider buying report presents recent insider purchases, reported on Forms 3, 4, and 5 filed with the SEC. The transactions are aggregated to a 'decision' level which simplifies the data analysis. A decision is a grouping of buying or selling by an individual at the specified company.
salesforce.com inc. (NYSE:CRM) - salesforce.com, inc. provides enterprise cloud computing solutions, with a focus on customer relationship management to companies. The company offers Sales Cloud to store data, monitor leads and progress, forecast opportunities, gain insights through relationship intelligence, and collaborate around sales on desktop and mobile devices, as well as solutions for partner relationship management. It also provides Service Cloud, which enables companies to deliver personalized customer service and support, as well as connects their service agents with customers on various devices; and Marketing Cloud to plan, personalize, and optimize one-to-one customer interactions. In addition, the company offers Commerce Cloud to deliver a digital commerce experience; Community Cloud to create and manage branded digital destinations for customers, partners, and employees; Internet of Things Cloud that provides insights to companies enabling them to sell, service, and market to their customers in personalized ways, as well as engage with them in real time; and Analytics Cloud that enables employees across an organization to explore business data, uncover new insights, make decisions, and take action from various devices. Further, it provides Salesforce Quip, a next-generation productivity solution for teams with a mobile-first strategy to collaborate without email; and Salesforce Platform for building enterprise apps. Additionally, the company offers professional cloud services, such as consulting, deployment, training, user-centric design, and integration to facilitate the adoption of its solutions; and architects and innovation program teams, as well as various education services comprising introductory online courses and advanced architecture certifications. salesforce.com, inc. sells its services through its direct sales force; and through consulting firms, systems integrators, and other partners. The company was founded in 1999 and is headquartered in San Francisco, California..
Royal Caribbean Cruises Ltd. (NYSE:RCL) - Royal Caribbean Cruises Ltd. operates as a cruise company. The company operates cruises under the Royal Caribbean International, Celebrity Cruises, and Azamara Club Cruises brand names. The Royal Caribbean International brand provides a range of itineraries ranging from 2 to 24 nights with options for onboard dining, entertainment, and other onboard activities to various destinations. The Celebrity Cruises brand offers itineraries ranging from 2 to 18 nights to various destinations; and operates onboard upscale ships that offer accommodations, fine dining, personalized services, and spa facilities. The Azamara Club Cruises brand offers cruise itineraries ranging from 3 to 21 nights that serve the up-market segment of the North American, the United Kingdom, and Australian markets. The company also operates ships under the partner brands, such as TUI Cruises, Pullmantur, and SkySea Cruises. As of December 31, 2016, the company operated 49 ships with itineraries ranging from 2 to 24 nights on approximately 535 destinations worldwide. Royal Caribbean Cruises Ltd. was founded in 1968 and is headquartered in Miami, Florida..
Nektar Therapeutics (NASDAQ:NKTR) - Nektar Therapeutics develops drug candidates that utilize its PEGylation and polymer conjugate technology platforms in the United States. Its product pipeline includes drug candidates in therapeutic areas comprising cancer, auto-immune disease, and chronic pain. The company offers MOVANTIK, an oral peripherally-acting opioid antagonist for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain; MOVENTIG for the treatment of opioid-induced constipation in adult patients who have an inadequate response to laxatives; and ADYNOVATE for use in treating Hemophilia A. Its drug candidates in clinical development stage comprises BAY41-6551, which is in Phase III clinical trial to treat gram-negative pneumonias; NKTR-214 that is in Phase 1/2 stage to treat cancer; NKTR-181 that is in Phase III clinical trial for treating chronic pain; and NKTR-358, to treat autoimmune diseases. The company s drug candidates in clinical development stage also include ONZEALD, a topoisomerase I inhibitor that is in Phase III clinical trial for metastatic breast cancer, as well as completed Phase II clinical trial stage for refractory ovarian cancer and second-line metastatic colorectal cancer; and in combination with 5-fluorouracil/leucovorin to treat refractory solid tumor cancers, which has completed Phase I clinical trial. In addition, it holds license, manufacturing, and supply agreements with Ophthotech Corporation for Fovista; and UCB Pharma for dapirolizumab pegol. Further, the company holds a range of license, manufacturing, and supply agreements with other biotechnology and pharmaceutical companies, including Amgen Inc.; Allergan, Inc.; Merck & Co., Inc.; Pfizer, Inc.; and F. Hoffmann-La Roche Ltd (Roche). Nektar Therapeutics was founded in 1990 and is headquartered in San Francisco, California..
Vical Incorporated (NASDAQ:VICL) - Vical Incorporated engages in the research and development of biopharmaceutical products based on its DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. Its product candidates include CyMVectin prophylactic vaccine for cytomegalovirus (CMV), which completed preclinical trial to prevent infection before pregnancy to preclude fetal transmission; therapeutic vaccine and prophylactic for herpes simplex virus type 2, which is under Phase 1/2 clinical trial to prevent and protect against recurring flare-ups, reduce viral shedding, and transmission; and VL-2397 antifungal, which is in Phase 1, for the treatment of fungal infections. The company, through corporate collaborations, is also developing ASP0113, which is under Phase III clinical trial for prevention of CMV reactivation in stem cell transplant recipients, as well as in Phase II clinical trial for prevention of CMV infection in kidney transplant recipients; and ONCEPT therapeutic cancer vaccine encoding human tyrosinase for the treatment to enhance survival time of dogs with oral melanoma. In addition, it engages in contract manufacturing of plasmid investigational products for various clients. The company was founded in 1987 and is headquartered in San Diego, California..
TTM Technologies Inc. (NASDAQ:TTMI) - TTM Technologies, Inc., together with its subsidiaries, manufactures printed circuit boards (PCBs) worldwide. It provides a range of PCBs and electro-mechanical solutions, including conventional PCBs, high density interconnect PCBs, flexible PCBs, rigid-flex PCBs, custom assemblies and system integration products, and IC substrates. It also produces test specialized circuits that are used in radio-frequency or microwave emission and collection applications; printed circuits with heavy copper cores, and embedded and press-fit coins; PCBs with electrically passive heat sinks; and PCBs with electrically active thermal cores. In addition, the company offers various services, including design for manufacturability, PCB layout design, simulation and testing, and quick turnaround services. The company s customers include original equipment manufacturers and electronic manufacturing services companies that primarily serve the networking/communications, cellular phone, computing, aerospace and defense, and medical/industrial/instrumentation end markets of the electronics industry; and the U.S. government. TTM Technologies, Inc. was founded in 1978 and is headquartered in Costa Mesa, California..
American Software Inc. (NASDAQ:AMSWA) - American Software, Inc. develops, markets, and supports a portfolio of software and services that deliver enterprise management and collaborative supply chain solutions worldwide. It operates in three segments: Supply Chain Management (SCM), Enterprise Resource Planning (ERP), and Information Technology (IT) Consulting. The SCM segment provides supply chain management solutions, including sales and operations planning, inventory and supply optimization, manufacturing planning and scheduling, manufacturing planning and scheduling, transportation optimization, and advanced retail planning solutions to streamline and optimize the forecasting, inventory, production, supply, allocation, distribution, and management of products between trading partners. This segment also markets and sells Demand Solutions product line to small and midsize enterprises; and offers Logility Voyager Solutions suite to customers with distribution-intensive supply chains. The ERP segment offers purchasing and materials management, customer order processing, financial, e-commerce, flow and traditional manufacturing solutions, as well as provides industry-specific business software to retailers and manufacturers in the apparel, sewn products, and furniture industries. The IT Consulting segment provides IT staffing and consulting services, such as professional/project management, staff augmentation, infrastructure and consulting, and social media and analytic marketing services; and support for software products comprising software enhancements, documentation, updates, customer education, consulting, systems integration, maintenance, and other support services. The company markets its products through direct and indirect sales channels, and agents to retail, apparel, consumer packaged goods, chemicals, oil and gas, life sciences, telecommunications, industrial products, and other manufacturing industries. American Software, Inc. was founded in 1970 and is headquartered in Atlanta, Georgia..
BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"
Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO
INVESTMENTS & TRADING
Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports
Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks
Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups
SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Valuation - Tracks all known valuation models and applies them.
GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies.
PatternScan - Automates tracking of every technical pattern and predicts next move in stocks.
Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders
Events - Tracks patterns directly correlated to specific events.
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.
Content Managed by News-Articles.NET